SCHEMBL16620032

SCHEMBL16620032

CN(C)Cc1ccc(NC(=O)C(F)(F)F)cc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.57
NR1H4 Q96RI1 1/20 0.57
MAPT P10636 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.44
GAA P10253 1/20 0.44
APEX1 P27695 1/20 0.43
MEN1 O00255 2/20 0.42
LMNA P02545 2/20 0.42
KMT2A Q03164 2/20 0.42
KDR P35968 1/20 0.42
NPY5R Q15761 2/20 0.41
HTT P42858 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
NPC1 O15118 1/20 0.41
HSP90AA1 P07900 1/20 0.41
NPY1R P25929 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16620122 0.81 EPHX2 (0.57) EPHX2NR1H4MAPTCYP1A2CYP2C9
SCHEMBL22060074 0.77 EPHX2 (0.66) EPHX2NR1H4MAPTCYP1A2CYP2C9
SCHEMBL22060072 0.77 EPHX2 (0.66) EPHX2NR1H4CYP1A2CYP2C9CYP2C19
SCHEMBL16620422 0.77 EPHX2 (0.54) EPHX2NR1H4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL4403329 0.77 EPHX1 (0.63) EPHX2MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL16621003 0.76 SMN1; SMN2 (0.60) EPHX2NR1H4MAPTCYP1A2CYP2C9
SCHEMBL4936391 0.75 CYP1A2 (0.47) EPHX2NR1H4MAPTCYP1A2CYP2C9
SCHEMBL9823940 0.74 MEN1 (0.52) EPHX2NR1H4MAPTCYP1A2CYP2C9
SCHEMBL13602467 0.74 L3MBTL1 (0.54) EPHX2NR1H4MAPTCYP1A2CYP2C9
SCHEMBL31495074 0.73 KDR (0.76) SMN1; SMN2MEN1LMNAKMT2AKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015049325-A1 THERAPEUTIC INHIBITORS OF CDK8 AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2015-04-09 WO disclosed
WO-2015049325-A1 THERAPEUTIC INHIBITORS OF CDK8 AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2015-04-09 WO disclosed
US-20150045255-A1 Endometrial Phase or Endometrial Cancer Biomarkers WALFISH, PAUL (CA) 2015-02-12 US disclosed